<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04584320</url>
  </required_header>
  <id_info>
    <org_study_id>NIMAO/2019-01/MdM01</org_study_id>
    <nct_id>NCT04584320</nct_id>
  </id_info>
  <brief_title>Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Hospitalization</brief_title>
  <acronym>ECUN-2</acronym>
  <official_title>Qualitative and Quantitative Identification of Clostridium Butyricum and Clostridium Neonatal in the Digestive Microbiota of Premature Infants Before 34 Weeks and Developing or Not Ulcerative Necrotizing Enterocolitis (NEC) During Their Hospitalization in Neonatology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigators hypothesize that Clostridium butyricum and Clostridium neonatal will&#xD;
      be more frequently found in the stool of preterm infants with ulcerative necrotizing&#xD;
      enterocolitis compared to healthy matched control infants. Systematic daily samples should&#xD;
      show that the kinetics of colonization precedes the onset of the pathology. Finally, the&#xD;
      systematic ecological survey at the time of infection could help understand the mode of&#xD;
      acquisition and transmission of these bacteria.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of C. butyricum</measure>
    <time_frame>Each day of hospitalization (maximum 120 days)</time_frame>
    <description>PCR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of C. neonatale</measure>
    <time_frame>Each day of hospitalization (maximum 120 days)</time_frame>
    <description>PCR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Culture of C. butyricum</measure>
    <time_frame>Each day of hospitalization (maximum 120 days)</time_frame>
    <description>Growth on selective media</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Culture of C. neonatale</measure>
    <time_frame>Each day of hospitalization (maximum 120 days)</time_frame>
    <description>Growth on selective media</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Localisation within the hospital</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Bed numbers occupied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Source of infection with C. butyricum and/or C. neonatale</measure>
    <time_frame>Time of infection (maximum 120 days)</time_frame>
    <description>swabs taken from bedding, care givers, milk products, parent stools</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Age of mother</measure>
    <time_frame>Day 0</time_frame>
    <description>Years</description>
  </other_outcome>
  <other_outcome>
    <measure>Body mass index of mother</measure>
    <time_frame>Day 0</time_frame>
    <description>Kg/m2</description>
  </other_outcome>
  <other_outcome>
    <measure>Parity of mother</measure>
    <time_frame>Day 0</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Gravidity of mother</measure>
    <time_frame>Day 0</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Professional activity of mother</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no; description</description>
  </other_outcome>
  <other_outcome>
    <measure>Smoking status of mother</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Chronic pathology of mother</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no, description</description>
  </other_outcome>
  <other_outcome>
    <measure>Allergy of mother</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no, description</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of years of schooling of mother</measure>
    <time_frame>Day 0</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Exposure to magnesium sulfate during pregnancy</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Cause of prematurity</measure>
    <time_frame>Day 0</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Method of delivery</measure>
    <time_frame>Day 0</time_frame>
    <description>Vagina/Caesarean</description>
  </other_outcome>
  <other_outcome>
    <measure>Anesthesia during delivery</measure>
    <time_frame>Day 0</time_frame>
    <description>General/spinal</description>
  </other_outcome>
  <other_outcome>
    <measure>Mode of delivery of vaginal birth</measure>
    <time_frame>Day 0</time_frame>
    <description>Spontaneous/instrumental</description>
  </other_outcome>
  <other_outcome>
    <measure>Spontaneous rupture of membranes</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Time of rupture of membranes before birth</measure>
    <time_frame>Day 0</time_frame>
    <description>&lt;12h/&gt;12h</description>
  </other_outcome>
  <other_outcome>
    <measure>Pathology during pregnancy</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/No; description</description>
  </other_outcome>
  <other_outcome>
    <measure>Birth term</measure>
    <time_frame>Day 0</time_frame>
    <description>Weeks and days</description>
  </other_outcome>
  <other_outcome>
    <measure>Birth weight</measure>
    <time_frame>Day 0</time_frame>
    <description>grams</description>
  </other_outcome>
  <other_outcome>
    <measure>Birth weight percentile</measure>
    <time_frame>Day 0</time_frame>
    <description>percentile</description>
  </other_outcome>
  <other_outcome>
    <measure>Birth height</measure>
    <time_frame>Day 0</time_frame>
    <description>cm</description>
  </other_outcome>
  <other_outcome>
    <measure>Birth height ; percentile</measure>
    <time_frame>Day 0</time_frame>
    <description>percentile</description>
  </other_outcome>
  <other_outcome>
    <measure>Intubation</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>umbilical venous catheter</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no; duration</description>
  </other_outcome>
  <other_outcome>
    <measure>Epicutaneo-cava catheter</measure>
    <time_frame>Day 0</time_frame>
    <description>Yes/no; duration</description>
  </other_outcome>
  <other_outcome>
    <measure>Daily lipid intake per os per kilp</measure>
    <time_frame>During hospitlization (maximum 120 days)</time_frame>
    <description>g/kg</description>
  </other_outcome>
  <other_outcome>
    <measure>Presence of sequelae</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of sequelae</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>description</description>
  </other_outcome>
  <other_outcome>
    <measure>Hemodynamically significant patent ductus arteriosus</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of milk</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>pasteurized/fresh/artificial</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of milk intake</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Probiotic intake duration</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Types of probiotic taken</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Type</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of antibiotics taken in post-natal period</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Type</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of antibiotic treatment in post-natal period</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of vasoactive amines taken</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Type</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of vasoactive amine treatment</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of any postnatal surgery</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Type</description>
  </other_outcome>
  <other_outcome>
    <measure>Total duration of parenteral feeding</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Ibuprofen</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Hemodynamic shock</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Labile Blood Product transfusion</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Amount</description>
  </other_outcome>
  <other_outcome>
    <measure>antenatal corticosteroid therapy</measure>
    <time_frame>Day 0</time_frame>
    <description>Complete/incomplete</description>
  </other_outcome>
  <other_outcome>
    <measure>Type of post-natal corticosteroid therapy</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Type</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of post-natal corticosteroid therapy</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Exposure to ante- and post-natal antibiotics</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Description</description>
  </other_outcome>
  <other_outcome>
    <measure>umbilical arterial catheter</measure>
    <time_frame>Day 0</time_frame>
    <description>Duration</description>
  </other_outcome>
  <other_outcome>
    <measure>Nosocomial infection</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Proven/suspected</description>
  </other_outcome>
  <other_outcome>
    <measure>Nosocomial infection infective agent</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>name</description>
  </other_outcome>
  <other_outcome>
    <measure>Rectal bleeding</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Number</description>
  </other_outcome>
  <other_outcome>
    <measure>metabolic acidosis</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Volume of alimentation per kilo</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Daily carbohydrate intake per os per kilp</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>g/kg</description>
  </other_outcome>
  <other_outcome>
    <measure>Daily proteins intake per os per kilp</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>g/kg</description>
  </other_outcome>
  <other_outcome>
    <measure>Volume of daily total alimentation</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Cranial circumference</measure>
    <time_frame>Day 0</time_frame>
    <description>cm; percentile</description>
  </other_outcome>
  <other_outcome>
    <measure>Cranial circumference percentile</measure>
    <time_frame>Day 0</time_frame>
    <description>percentile</description>
  </other_outcome>
  <other_outcome>
    <measure>Other catheter</measure>
    <time_frame>Day 0</time_frame>
    <description>Type</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of other catheter</measure>
    <time_frame>Day 0</time_frame>
    <description>Days</description>
  </other_outcome>
  <other_outcome>
    <measure>Enriched maternal milk</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Maximum percentage</description>
  </other_outcome>
  <other_outcome>
    <measure>Milk thickening</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Duration</description>
  </other_outcome>
  <other_outcome>
    <measure>Chorioamnionitis</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Proven/suspected</description>
  </other_outcome>
  <other_outcome>
    <measure>Materno-fetal infection</measure>
    <time_frame>Day 0</time_frame>
    <description>Proven/suspected</description>
  </other_outcome>
  <other_outcome>
    <measure>Materno-fetal infection infective agent</measure>
    <time_frame>Day 0</time_frame>
    <description>name</description>
  </other_outcome>
  <other_outcome>
    <measure>pneumatosis-pneumoportia</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Transfer</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>Yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Time of occurence of ulcerative necrotizing enterocolitis</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>weeks post-natal</description>
  </other_outcome>
  <other_outcome>
    <measure>Warning signs of ulcerative necrotizing enterocolitis</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Duration of bowel rest following necrotizing enterocolitis</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Bell staging of ulcerative necrotizing enterocolitis</measure>
    <time_frame>During hospitalization (maximum 120 days)</time_frame>
    <description>from IA (suspected necrotizing enterocolitis) to IIIB (advanced necrotizing enterocolitis)</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <arm_group>
    <arm_group_label>Premature neonates with necrotizing enterocolitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Premature neonates without necrotizing enterocolitis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stool sample</intervention_name>
    <description>Stools samples taken daily to test for present of Clostridium butyricum and Clostridium neonatale</description>
    <arm_group_label>Premature neonates with necrotizing enterocolitis</arm_group_label>
    <arm_group_label>Premature neonates without necrotizing enterocolitis</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool samples taken daily from nappies&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of all newborns born less than 34 weeks of gestation admitted&#xD;
        to the neonatology department of the CHU de Nîmes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Premature newborn with a term of birth ≤ 34 weeks of gestation admitted to the&#xD;
             neonatology department at the CHU of Nîmes.&#xD;
&#xD;
          -  Affiliated or beneficiary of a health insurance plan.&#xD;
&#xD;
          -  Newborn whose parents received informed information about the study and did not&#xD;
             express their opposition to their child's participation in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Newborn with malformative digestive pathology&#xD;
&#xD;
          -  Newborn baby participating in another category 1 trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo De Maio</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Massimo De Maio</last_name>
    <phone>04.66.68.33.05</phone>
    <email>massimo.dimaio@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>04.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Massimo Di Maio</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Philippe Lavigne</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maryam Safarian</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibaut Chapon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard La Scola</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nadim Cassir</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2020</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>low-birth weight infant</keyword>
  <keyword>Clostridium butyricum</keyword>
  <keyword>Clostridium neonatale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

